|
G |
Ace |
angiotensin I converting enzyme |
disease_progression |
ISO |
DNA:polymorphism:intron: CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Susceptibility to progression to renal failure in IgA nephropathy |
CTD ClinVar RGD |
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:15118671 PMID:12220450 More...
|
RGD:1331525, RGD:7257515 |
NCBI chr10:91,410,129...91,430,246
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
disease_progression |
ISO |
DNA:polymorphism: : |
RGD |
PMID:12484505 |
RGD:7241283 |
NCBI chr 1:174,133,260...174,159,966
|
|
G |
Adam10 |
ADAM metallopeptidase domain 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32715474 |
|
NCBI chr 8:71,346,008...71,477,889
|
|
G |
Add1 |
adducin 1 |
disease_progression |
ISO |
DNA:polymorphism:cds:rs4961(human) |
RGD |
PMID:19838659 |
RGD:7174725 |
NCBI chr14:76,108,643...76,167,267
|
|
G |
Add2 |
adducin 2 |
disease_progression |
ISO |
DNA:polymorphism:cds: rs4984(human) |
RGD |
PMID:19838659 |
RGD:7174725 |
NCBI chr 4:118,444,594...118,538,505
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9259580 |
|
NCBI chr19:69,426,540...69,447,017
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
ISO |
protein:increased expression:kidney tubule |
RGD |
PMID:15930094 |
RGD:6903851 |
NCBI chr17:34,383,397...34,435,523
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
disease_progression |
ISO |
DNA:polymorphism: :1818A>T (human) protein:increased expression:kidney tubule |
RGD |
PMID:19194560 PMID:15930094 |
RGD:6903844, RGD:6903851 |
NCBI chr X:116,914,320...116,918,504
|
|
G |
Aurkb |
aurora kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr10:54,243,116...54,249,675
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
|
ISS |
OMIM:161950 | OMIM:616818 |
MouseDO |
|
|
NCBI chr 5:55,935,614...55,982,461
|
|
G |
C1qa |
complement C1q A chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8840296 PMID:25133636 |
|
NCBI chr 5:154,417,086...154,419,933
|
|
G |
C1qb |
complement C1q B chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 5:149,118,843...149,124,394
|
|
G |
C2 |
complement C2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr20:3,951,474...3,970,376
|
|
G |
C3 |
complement C3 |
|
ISO |
mRNA,protein:increased expression, increased activity:kidney |
RGD |
PMID:11287758 |
RGD:7175543 |
NCBI chr 9:2,174,412...2,201,339
|
|
G |
Card9 |
caspase recruitment domain family, member 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25305756 |
|
NCBI chr 3:29,569,907...29,578,402
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
protein:increased expression:kidney |
RGD |
PMID:18433541 |
RGD:2307041 |
NCBI chr10:67,503,077...67,504,875
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
disease_progression |
ISO |
|
RGD |
PMID:23192593 |
RGD:7483632 |
NCBI chr 9:91,837,139...91,839,736
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
disease_progression |
ISO |
|
RGD |
PMID:23192593 |
RGD:7483632 |
NCBI chr 1:55,022,037...55,055,857
|
|
G |
Cd14 |
CD14 molecule |
disease_progression |
ISO |
DNA:polymorphism:promoter:c. -159C>T (human) |
RGD |
PMID:12566518 |
RGD:7204499 |
NCBI chr18:28,609,558...28,611,409
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 4:157,085,080...157,118,470
|
|
G |
Cd44 |
CD44 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 3:109,610,824...109,699,776
|
|
G |
Cfb |
complement factor B |
disease_progression |
ISO |
mRNA:increased expression:kidney protein:increased expression:serum |
RGD |
PMID:8567024 PMID:3118258 PMID:17385664 |
RGD:7242737, RGD:7242754, RGD:7242759 |
NCBI chr20:3,970,643...3,976,510
|
|
G |
Cfhr1 |
complement factor H-related 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21399633 |
|
NCBI chr13:51,395,583...51,410,571
|
|
G |
Chga |
chromogranin A |
|
ISO |
associated with Hypertension;DNA:polymorphism:promoter:-415T>C (human) |
RGD |
PMID:20113265 |
RGD:6906902 |
NCBI chr 6:121,696,051...121,707,399
|
|
G |
Coro1c |
coronin 1C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr12:42,713,024...42,785,179
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
DNA:SNPs: :rs4674257, rs4674259 (human) |
RGD |
PMID:21214373 |
RGD:7257677 |
NCBI chr 9:75,729,493...75,735,868
|
|
G |
Defa5 |
defensin alpha 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22197929 PMID:25305756 |
|
NCBI chr16:70,342,530...70,344,854
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
|
ISO |
protein:increased expression:urine (human) |
RGD |
PMID:16118482 |
RGD:1578453 |
NCBI chr 4:104,744,302...104,753,119
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
IDA |
|
RGD |
PMID:29844269 |
RGD:13792576 |
NCBI chr 1:241,212,155...241,245,774
|
|
G |
Fcar |
Fc alpha receptor |
|
ISO |
|
RGD |
PMID:22451718 PMID:21985370 |
RGD:7242063, RGD:7242167 |
NCBI chr 1:69,626,458...69,660,558
|
|
G |
Fcgr3a |
Fc gamma receptor 3A |
disease_progression |
ISO |
DNA:polymorphism:exon:p.F176V(human) |
RGD |
PMID:16221721 |
RGD:5508463 |
NCBI chr13:85,782,636...85,792,656
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:15925904 |
RGD:7206844 |
NCBI chr 9:80,645,507...80,714,200
|
|
G |
Foxm1 |
forkhead box M1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 4:163,325,628...163,338,100
|
|
G |
Gpr183 |
G protein-coupled receptor 183 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr15:105,445,129...105,457,192
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:23135864 PMID:21467131 |
RGD:7245479, RGD:7245983 |
NCBI chr10:31,118,667...31,151,730
|
|
G |
Hpse |
heparanase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr14:9,200,971...9,241,377
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
ISO |
DNA: snp::rs2229765 |
RGD |
PMID:21047277 |
RGD:7242795 |
NCBI chr 1:130,959,787...131,248,664
|
|
G |
Il18 |
interleukin 18 |
|
ISO |
|
RGD |
PMID:22518072 |
RGD:6893446 |
NCBI chr 8:59,802,072...59,829,275
|
|
G |
Il1a |
interleukin 1 alpha |
no_association |
ISO |
DNA:SNP:promoter:-889C>T (human) |
RGD |
PMID:21049406 |
RGD:6907116 |
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Il1b |
interleukin 1 beta |
no_association |
ISO |
DNA:SNPs: :rs1143627, rs3917356, rs1143633 (human) |
RGD |
PMID:19280228 PMID:21049406 |
RGD:6907082, RGD:6907116 |
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
susceptibility |
ISO |
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human) DNA:polymorphisms:intron, 3' utr:IVS1+1890G>T, IVS1+8796A>G, *138C>G (rs928940, rs439154, rs315951) (human) protein:decreased expression:serum, urine (human) rat model treated with human protein response to immunoglobulin therapy mouse model treated with human protein |
RGD |
PMID:10916103 PMID:19280228 PMID:16209246 PMID:10566895 PMID:10079261 PMID:9844059 PMID:9370186 More...
|
RGD:6906961, RGD:6907082, RGD:6907414, RGD:6907427, RGD:6909131, RGD:6909132, RGD:6909150 |
NCBI chr 3:27,509,836...27,525,738
|
|
G |
Kif15 |
kinesin family member 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 8:131,479,340...131,550,209
|
|
G |
Lair1 |
leukocyte-associated immunoglobulin-like receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 1:79,140,850...79,261,546
|
|
G |
Laptm5 |
lysosomal protein transmembrane 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 5:143,087,759...143,109,807
|
|
G |
Lcn2 |
lipocalin 2 |
|
ISO |
protein:increased expression:urine: |
RGD |
PMID:21467131 |
RGD:7245983 |
NCBI chr 3:36,078,432...36,081,851
|
|
G |
Lhfpl2 |
LHFPL tetraspan subfamily member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 2:25,281,771...25,428,128
|
|
G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr19:23,055,092...23,074,398
|
|
G |
Mertk |
MER proto-oncogene, tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 3:136,391,936...136,498,366
|
|
G |
Mir20a |
microRNA 20a |
disease_progression |
ISO |
|
RGD |
PMID:29459010 |
RGD:25823149 |
NCBI chr15:92,181,084...92,181,168
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
IEP |
mRNA:increased expression:glomerulus |
RGD |
PMID:9848780 |
RGD:2314955 |
NCBI chr15:27,887,795...27,897,020
|
|
G |
Ms4a6a |
membrane spanning 4-domains A6A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 1:208,401,465...208,414,831
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
|
ISO |
DNA:polymorphism:Cds :2756A>G(human) |
RGD |
PMID:21737517 |
RGD:7207085 |
NCBI chr17:62,911,705...62,996,544
|
|
G |
Muc20 |
mucin 20, cell surface associated |
disease_progression |
ISO |
DNA:repeat |
RGD |
PMID:16508246 |
RGD:7364789 |
NCBI chr11:67,987,816...68,001,496
|
|
G |
Ngf |
nerve growth factor |
|
ISO |
DNA:SNP: :rs11102930 (human) |
RGD |
PMID:21178826 |
RGD:7242801 |
NCBI chr 2:192,589,580...192,642,971
|
|
G |
Notch2 |
notch receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32715474 |
|
NCBI chr 2:185,610,594...185,744,088
|
|
G |
Otub1 |
OTU deubiquitinase, ubiquitin aldehyde binding 1 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:22279542 |
RGD:7175260 |
NCBI chr 1:204,387,215...204,395,495
|
|
G |
Pde5a |
phosphodiesterase 5A |
|
ISO |
DNA:SNP: :rs13124532(human) |
RGD |
PMID:20563733 |
RGD:7248685 |
NCBI chr 2:210,858,515...211,003,480
|
|
G |
Pigr |
polymeric immunoglobulin receptor |
|
ISO |
ClinVar Annotator: match by term: IgA glomerulonephritis |
ClinVar |
PMID:12740691 PMID:16282702 |
|
NCBI chr13:42,298,905...42,326,877
|
|
G |
Pla2g7 |
phospholipase A2 group VII |
disease_progression |
ISO |
DNA:polymorphism:exon: |
RGD |
PMID:12220450 |
RGD:7257515 |
NCBI chr 9:17,362,214...17,404,476
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:9002298 |
|
NCBI chr15:3,505,485...3,511,987
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 1:143,659,312...143,681,019
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :HLA-DQB1*0301(human) |
CTD RGD |
PMID:25305756 PMID:7638860 |
RGD:36174018 |
NCBI chr20:4,598,475...4,604,118
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
disease_progression |
ISO ISS |
OMIM:161950 | OMIM:616818 |
MouseDO RGD |
PMID:11967037 |
RGD:6903255 |
NCBI chr 1:215,406,138...215,409,686
|
|
G |
Sele |
selectin E |
|
ISO |
DNA:SNP:exon:p.H468Y (human) ClinVar Annotator: match by term: IgA nephropathy, susceptibility to |
ClinVar RGD |
PMID:11828340 PMID:16282702 PMID:11828340 |
RGD:1625253 |
NCBI chr13:78,935,997...78,945,905
|
|
G |
Sell |
selectin L |
|
ISO |
|
RGD |
PMID:17452405 PMID:11828340 |
RGD:7175290, RGD:1625253 |
NCBI chr13:78,950,100...78,969,604
|
|
G |
Serpinb7 |
serpin family B member 7 |
disease_progression |
ISO |
DNA:SNPs:3' utr:2093C>T, 2180C>T (human) DNA:SNP: :23167A>G (human) DNA:SNP:5' utr, exon:267G>A (human) |
RGD |
PMID:18793525 PMID:16550745 PMID:16796905 |
RGD:7207366, RGD:7207372, RGD:7207380 |
NCBI chr13:23,369,830...23,442,205
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
ISO |
|
RGD |
PMID:24744439 |
RGD:12859042 |
NCBI chr 4:6,954,017...6,963,170
|
|
G |
Slc43a3 |
solute carrier family 43, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr 3:70,008,160...70,030,324
|
|
G |
Spry2 |
sprouty RTK signaling antagonist 2 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: IgA nephropathy, susceptibility to, 3 |
OMIM CTD ClinVar |
PMID:25741868 PMID:25782674 |
|
NCBI chr15:82,692,291...82,697,408
|
|
G |
St6galnac2 |
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17480010 |
|
NCBI chr10:101,910,220...101,928,412
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
disease_progression no_association |
ISO |
DNA:SNP: :rs7561832 (human) DNA:SNP:intron:c.274-28828C>G (rs10181656) (human) |
RGD |
PMID:20045654 PMID:20479942 |
RGD:7207872, RGD:7207878 |
NCBI chr 9:49,472,660...49,588,540
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11728950 |
|
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr X:3,766,509...3,772,578
|
|
G |
Tlr1 |
toll-like receptor 1 |
susceptibility |
ISO |
DNA:snps:promoter, cds:g.-414C>T, p.N248S (rs5743557, rs4833095) (human) |
RGD |
PMID:21108742 |
RGD:7246898 |
NCBI chr14:43,737,761...43,750,389
|
|
G |
Tlr9 |
toll-like receptor 9 |
severity treatment |
ISO |
DNA, mRNA:SNP, increased expression:exon, spleen:g.159C>G (mouse) DNA:SNPs:intron, exon:IVS4-44A>G, c.1635G>A (rs352139, rs352140) (human) associated with Graft vs Host Disease associated with Graft vs Host Disease; mRNA:increased expression:splenocyte (mouse) |
RGD |
PMID:18776126 PMID:18776126 PMID:21621468 PMID:21621468 |
RGD:7246889, RGD:7246889, RGD:7246893, RGD:7246893 |
NCBI chr 8:115,743,407...115,747,523
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
|
RGD |
PMID:9844059 |
RGD:6909132 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
treatment |
ISO |
protein:increased expression:serum |
RGD |
PMID:16209246 PMID:9844059 |
RGD:6907414, RGD:6909132 |
NCBI chr 4:159,837,119...159,849,817
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
treatment |
ISO |
protein:increased expression:serum |
RGD |
PMID:16209246 PMID:9844059 |
RGD:6907414, RGD:6909132 |
NCBI chr 5:157,070,642...157,104,216
|
|
G |
Tnfsf13 |
TNF superfamily member 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22197929 |
|
NCBI chr10:54,400,054...54,403,723
|
|
G |
Tnfsf13b |
TNF superfamily member 13b |
|
ISS |
OMIM:161950 |
MouseDO |
|
|
NCBI chr16:79,462,406...79,492,888
|
|
G |
Tnfsf14 |
TNF superfamily member 14 |
|
ISS |
OMIM:161950 |
MouseDO |
|
|
NCBI chr 9:2,155,270...2,160,100
|
|
G |
Vav3 |
vav guanine nucleotide exchange factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25305756 |
|
NCBI chr 2:199,699,861...200,042,344
|
|
G |
Vsig4 |
V-set and immunoglobulin domain containing 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25133636 |
|
NCBI chr X:61,144,926...61,170,212
|
|
G |
Was |
WASP actin nucleation promoting factor |
|
ISS |
OMIM:161950 | OMIM:616818 |
MouseDO |
|
|
NCBI chr X:17,077,057...17,085,802
|
|